Previvo Genetics

San Jose, United States Founded: 2012 • Age: 14 yrs
Preimplantation genetic diagnostics and embryo screening devices are developed.
Request Access

About Previvo Genetics

Previvo Genetics is a company based in San Jose (United States) founded in 2012 by John Buster.. Previvo Genetics has raised $6.83 million across 2 funding rounds. Previvo Genetics operates in a competitive market with competitors including Gynesonics, Minerva Surgical, Channel Medsystems, NX Prenatal and LUMINELLE, among others.

  • Headquarter San Jose, United States
  • Founders John Buster
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Previvo Genetics, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.83 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.41 M (USD), Series A

    Sep 23, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Previvo Genetics

Previvo Genetics has successfully raised a total of $6.83M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.41 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $3.4M
  • First Round

    (08 Sep 2016)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2016 Amount Series A - Previvo Genetics Valuation

investors

Sep, 2016 Amount Series A - Previvo Genetics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Previvo Genetics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Previvo Genetics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Previvo Genetics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Previvo Genetics

Previvo Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynesonics, Minerva Surgical, Channel Medsystems, NX Prenatal and LUMINELLE, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A minimally invasive ablation system for uterine fibroids is developed.
domain founded_year HQ Location
Minerva Surgical is focused on uterine health solutions.
domain founded_year HQ Location
Cryothermic technology for endometrial ablation to control heavy bleeding
domain founded_year HQ Location
Early warning blood tests for pregnancy complications are provided.
domain founded_year HQ Location
Hysteroscopy system is developed for minimally invasive endometrial procedures.
domain founded_year HQ Location
Diagnostic technologies for early disease detection are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Previvo Genetics

Frequently Asked Questions about Previvo Genetics

When was Previvo Genetics founded?

Previvo Genetics was founded in 2012 and raised its 1st funding round 4 years after it was founded.

Where is Previvo Genetics located?

Previvo Genetics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Is Previvo Genetics a funded company?

Previvo Genetics is a funded company, having raised a total of $6.83M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.41M, raised on Sep 08, 2016.

What does Previvo Genetics do?

Founded in 2012 in San Jose, United States, Previvo Genetics operates in the biotechnology sector focused on reproductive health. The companys Previvo Uterine Lavage System is utilized to extract post-IVF blastocysts from the uterus noninvasively. These embryos are then screened for genetic abnormalities, with viable ones selected for re-implantation to support fertility treatments.

Who are the top competitors of Previvo Genetics?

Previvo Genetics's top competitors include Gynesonics, NX Prenatal and Channel Medsystems.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available